GlassScriptPhysician profile
Lawrence P Mckean
NPI 1891891982
$4,657.21
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $931 · 2020: $629 · 2021: $996 · 2022: $1,073 · 2023: $1,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963 · Education: $44.18 · Consulting Fee: $21.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.43 |
| Education | $44.18 |
| Consulting Fee | $21.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $525.03 | 2019-2021 | |
| Grifols USA, LLC | $469.68 | 2019-2023 | Xembify |
| Astrazeneca Pharmaceuticals LP | $460.68 | 2019-2023 | Fasenra |
| Chiesi USA, INC. | $300.48 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $288.23 | 2021-2023 | Cuvitru |
| Pfizer INC. | $276.21 | 2020-2023 | |
| Abbvie INC. | $274.99 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $187.33 | 2022-2023 | Dupixent |
| Csl Behring | $184.75 | 2019-2023 | Hizentra, Haegarda |
| Bio Products Laboratory USA, INC. | $171.77 | 2020-2023 | Gammaplex, Coagadex |
| Hill-Rom Company, INC | $150.00 | 2021 | |
| Genzyme Corporation | $141.34 | 2021-2023 | |
| Allergan, INC. | $135.52 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $94.52 | 2021-2022 | |
| Pharming Healthcare, INC. | $94.27 | 2022-2023 | Ruconest |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $89.51 | 2019-2023 | Grastek, Odactra, Ragwitek |
| Adma Biomanufacturing LLC | $85.26 | 2021-2023 | |
| Nestle Healthcare Nutrition INC. | $84.37 | 2020-2022 | |
| Mylan Specialty L.P. | $83.70 | 2019-2023 | |
| Optinose US, INC. | $69.63 | 2020-2021 | |
| Octapharma USA, INC. | $68.44 | 2020-2022 | |
| Philips North America LLC | $67.17 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $54.32 | 2021-2022 | |
| Aimmune Therapeutics, INC. | $46.45 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $38.07 | 2021-2022 | |
| Insmed, INC. | $36.84 | 2019 | |
| Amgen INC. | $34.19 | 2022 | |
| Baxter Healthcare | $30.27 | 2023 | Hillrom - Monarch Airway Clearance System |
| Hikma Pharmaceuticals USA | $27.12 | 2023 | Ryaltris |
| Digestive Care, INC. | $20.54 | 2023 | Pertzye |
| Vivus LLC | $20.04 | 2022 | |
| Genentech USA, INC. | $16.14 | 2022 | |
| Shire North American Group INC | $15.82 | 2019 | |
| Advanced Respiratory, INC | $14.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Mckean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.